Institut Català d'Oncologia de L'Hospitalet (ICO L'Hospitalet)
Barcelona 08908
0 studies enrolling now · 1 studies all time
What they study most
Glioblastoma
Studies at this site
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
— Recruiting now